It is often hard to find a platform that can deal with all your corporate needs or provides you with correct instruments to manage document creation and approval. Picking a software or platform that includes important document creation instruments that simplify any process you have in mind is crucial. Although the most popular format to work with is PDF, you need a comprehensive solution to deal with any available format, such as AMI.
DocHub ensures that all your document creation demands are taken care of. Revise, eSign, rotate and merge your pages in accordance with your needs with a mouse click. Deal with all formats, such as AMI, effectively and . Regardless of the format you start working with, it is possible to convert it into a required format. Preserve tons of time requesting or looking for the proper file type.
With DocHub, you do not need more time to get comfortable with our user interface and modifying process. DocHub is an easy-to-use and user-friendly software for any individual, even those without a tech education. Onboard your team and departments and transform file administration for the company forever. embed frame in AMI, create fillable forms, eSign your documents, and have processes done with DocHub.
Take advantage of DocHub’s comprehensive feature list and swiftly work with any file in any format, which includes AMI. Save time cobbling together third-party platforms and stay with an all-in-one software to further improve your daily processes. Begin your free DocHub trial subscription right now.
[Music] welcome to esc tv barcelona were here at the esc 2022 in barcelona and im joined here by my colleague joe young han from korea to discuss the results of the frame ami trial i am stefan james professor of cardiology upsell university in sweden jo young you presented your results yesterday you were addressing an important clinical question how we should identify lesions to revascularize in patients with multivessen disease suffering from acs stemi or non-stemi can you please briefly tell the tell us about the results of your trial yeah we compared ffa guided pci versus angiography guided pci for a treatment of non-inflammated artery lesions but the primary endpoint of our study was the composite of death mi and the repeat with vascularization so we ignored 562 patients and we randomly assigned these patients to the ffa guided pci group or angiography guided pci group in a one-ton fashion during a three and a half years median follow-up the primary endpoint occurred less freque